Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980-95

British Journal of Dermatology

Volumn 140, Issue 3, 1999, Pages 463-467

  Van Der Rhee, H J ^a,b   Van Der Spek Keijser, L M T ^b,c   Van Westering, R ^b   Coebergh, J W W ^b,d  

^a LEYENBURG HOSPITAL   (Netherlands)

^b CCCW Stud Grp for Dermato oncology   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Dept of Clin Epidemiol/Univ H ^*  (Netherlands)

Author keywords

Breslow thickness; Incidence; Malignant melanoma; Mortality; Netherlands; Skin cancer campaign

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NETHERLANDS; PRIORITY JOURNAL;

AGED; FEMALE; HEALTH PROMOTION; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0032939380     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02710.x     Document Type: Article

References (26)

1. 1 Coleman MP, Estève J, Damiecki P et al. Melanoma of skin (ICD-9 172). In: Trends in Cancer Incidence and Mortality (Coleman MP, Estève J, Damiecki P et al. eds). Lyon: IAKC Scientific Publications No. 121, 1993: 387-401.
2. 2 Doherty VR, MacKie RM. Experience of a public education programme on early detection of cutaneous malignant melanoma. Br Med J 1988; 297: 388-91.
3. 3 MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992; 304: 1012-15.
4. 4 Graham-Brown RAC, Osborne JE, London SP et al. The initial effects on workload and outcome of a public education campaign on diagnosis and treatment of malignant melanoma in Leicestershire. Br J Dermatol 1990; 122: 53-9.
5. 5 Cistofoline M, Bianchi R, Boi S et al. Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer 1993; 71: 370-4.
6. 6 Krol S, Keijser LMT, van der Rhee HJ et al. Screening for skin cancer in the Netherlands. Acta Derm Venereol (Stockh) 1991; 71: 317-21.
7. 7 van der Spek-Keijser LMT, van der Rhee HJ, Bergman W et al. Screening for skin cancer: differences in risk factors between a self-selected and a nonselected population. Cancer Prev Int 1994; 1: 83-8.
8. 8 van der Spek-Keijser LMT, van der Rhee HJ, Hartevelt HM et al. Screening for skin cancer: differences in yield between a self-selected and a nonselected population. Cancer Prev Int 1994; 1: 89-93.
9. 9 van der Spek-Keijser LMT, van der Rhee HJ, Toth G et al. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol 1997; 136: 565-71.
10. 10 MacKie R, Hunter JAA, Aitchison TC et al. Cutaneous malignant melanoma Scotland 1979-89. Lancet 1992; 339: 971-5.
11. 11 Thörn M, Pontén F, Bergström R et al. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. Br J Cancer 1994; 70: 743-8.
12. 12 Thörn M, Pontén F, Bergström R et al. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86: 761-9.
13. 13 Garbe C, Wiebelt H, Orfanos CE. Change of epidemiological characteristics of malignant melanoma during the years 1962-72 and 1983-86 in the Federal Republic of Germany. Dermatologica 1989; 178: 131-5.
14. 14 Aase A, Bentham G. Gender, geography and socio-economic status in the diffusion of malignant melanoma risk. Soc Sci Med 1996; 42: 1621-17.
15. 15 Chen YT, Zheng T, Holford TR et al. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 1994; 3: 541-50.
16. 16 Dennis LK, White E, Lee JAH. Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 1993; 4: 93-100.
17. 17 Mackie RM, Hole D, Hunter JAA et al. Cutaneous malignant melanoma in Scotland: incidence, survival and mortality 1979-94. Br Med J 1997; 315: 1117-22.
18. 18 Visser O, Coebergh JWW, Schouten LJ et al. In: Incidence of Cancer in the Netherlands. Utrecht: Netherlands Cancer Registry, 1994: 29-31.
19. 19 Nelemans PJ, Kiemeney LALM, Rampen FHJ et al. Trends in mortality from malignant cutaneous melanoma in the Netherlands 1950-88. Eur J Cancer 1993; 29A: 107-11.
20. 20 Roush GC, McKay L, Holford TR. A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer 1992; 69: 1714-20.
21. 21 Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 1995; 24: 897-907.
22. 22 Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3: 395-401.
23. 23 White E, Kirkpatrick CS, Lee JAH. Case-control study of malignant melanoma in Washington State. Am J Epidemiol 1994; 139: 857-68.
24. 24 Setlow RB, Woodhead AD. Temporal changes in the incidences of malignant melanoma: explanation from action spectra. Mutat Res 1494; 307: 365-74.
25. 25 Lee JAH. Declining effect of latitude on melanoma mortality rates in the United States. Am J Epidemiol 1997; 146: 413-17.
26. 26 Tersmette AC, Coebergh JWW, van Casparie-Velsen IJA et al. Invasive cutaneous melanoma in the Netherlands 1989-1990, Eur J Cancer Prevention 1996; 5: 69-74.